Hospital

HRSA moves forward with the 340B Rebate Model Pilot Program, raising concerns among health care providers about financial impacts and operational challenges.

The National Lipid Association aims to enhance the science and practice of lipidology and promote optimal cardiometabolic health.

Leaders inspire the profession to reach higher levels, adapt, and embrace the future.

Examining Trends From Past Respiratory Virus Seasons Can Inform New Vaccination Strategies

Expanding lung cancer screening to an age-based model significantly enhances early detection, potentially saving over 26,000 lives annually in the US.

Pharmacists remain essential to ensuring patients receive safe, effective, and accessible care amid expanding therapies.

Research funding disruptions at the National Institutes of Health (NIH) impact clinical trials, threatening treatment options for patients and highlighting the critical role of pharmacists in care continuity.

Thunderstorms significantly increase asthma-related emergency visits, highlighting the need for storm-specific preparedness and management strategies for patients.

A new FDA-approved sublingual form of cyclobenzaprine HCl shows promising efficacy and tolerability in fibromyalgia.

High-dose busulfan-melphalan enhances VRd therapy, improving progression-free survival in high-risk multiple myeloma patients undergoing ASCT.

CAR T-cell therapy shows promise for treating HER2-positive breast cancer with CNS metastases, offering a novel approach to improve patient outcomes.

The FDA approved durvalumab with FLOT chemotherapy, revolutionizing treatment for early gastric and gastroesophageal junction cancers, enhancing survival rates.

New research reveals how age, lifestyle, and diabetes alter the gluteus maximus shape, highlighting sex-specific responses and metabolic health implications.

With this approval, Itvisma has become the first and only gene replacement therapy available for children 2 years and older, teenagers, and adults with SMA.

Understanding these medications is essential for their effective use.

City-level COVID-19 vaccine mandates in the US have limited impact on vaccination rates and health outcomes.

Oncology pharmacists unpack cGVHD care, highlighting axatilimab’s mechanism, safety monitoring, and team-based strategies to optimize outcomes.

The legislation is effective on January 1, 2026.

Data show the overall use of sodium-glucose cotransporter 2 (SGLT2) inhibitors among study participants with chronic kidney disease (CKD) was about 14.8%.

Pharmacists support acute pain management in patients on MOUD through education, optimizing therapy, guiding analgesia, and ensuring safe transitions of care.

Advanced IHC assays enhance HER2-low breast cancer detection, improving treatment eligibility for trastuzumab deruxtecan.

Particularly, younger women with chronic kidney disease (CKD) experienced the greatest survival disadvantage.

Emergency medicine pharmacists discuss how they used a gamified, PowerPoint-based virtual escape room to improve disaster preparedness training, strengthen critical thinking, and highlight the essential role of pharmacists in emergency management.

The findings from the BATURA clinical trial were presented at the 2025 ACAAI Annual Scientific Meeting.

The program’s legitimacy rests on transparency, audits, and ensuring benefits reach vulnerable patients.